tirzepatide semaglutide therapeutic modality versus Once Weekly in Patients with Type 2 Diabetes Tirzepatide vs Semaglutide - GLP-1

In a head-to-head trial against a full-strength GLP-1 drug, tirzepatide reduced food craving without changing measured restraint. Slower stomach emptying also makes smaller portions feel filling for longer. People whose eating was driven by stress, reward, or constant mental effort often describe the quiet as relief

In studies with rats and mice, liraglutide injection and medicines that work like liraglutide injection caused thyroid tumors, including thyroid cancer

doi: 10.3389/fnut.2022.861750 Received 25 January 2022 Accepted 29 March 2022 Published 26 April 2022 Volume 9 - 2022 Edited by Hui-Xin Liu, China Medical University, China Reviewed by Xingen Lei, Cornell University, United States

There are no known interactions between tirzepatide or semaglutide and over-the-counter analgesics

Early Phase (weeks 1-4) Mild nausea most common during the first 24-48 hours post-injection